| 1 |
Chang L, Cash BD, Lembo A, Kunkel DC, English BA, Lindstrom B, Gu G, Skare S, Gilder K, Turner S, Cataldi F, Lipkis D, Jan T. Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo-controlled trial (CAPTIVATE). Neurogastroenterol Motil 2023;:e14539. [PMID: 36740814 DOI: 10.1111/nmo.14539] [Reference Citation Analysis]
|
| 2 |
Vijayvargiya P, Breen-Lyles M, Nord SL, Maselli D, Busciglio I, Boinpally R, Muslin A, Carrothers TJ, Camilleri M. Safety and Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome-Diarrhea With or Without Bile Acid Diarrhea: Open-Label Study. Dig Dis Sci 2022;67:3911-21. [PMID: 35122592 DOI: 10.1007/s10620-022-07379-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Febo-rodriguez L, Saps M. Abdominal Pain-Related Functional Gastrointestinal Disorder and Disorders of Brain–Gut Interactions. Pediatric Neurogastroenterology 2022. [DOI: 10.1007/978-3-031-15229-0_37] [Reference Citation Analysis]
|
| 4 |
Liu JJ, Brenner DM. Review article: current and future treatment approaches for IBS with constipation. Aliment Pharmacol Ther 2021;54 Suppl 1:S53-62. [PMID: 34927760 DOI: 10.1111/apt.16607] [Reference Citation Analysis]
|
| 5 |
Van den Houte K, Colomier E, Schol J, Carbone F, Tack J. Recent advances in diagnosis and management of irritable bowel syndrome. Curr Opin Psychiatry 2020;33:460-6. [PMID: 32639360 DOI: 10.1097/YCO.0000000000000628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 6 |
Lembo AJ, Covington PS, Dove LS, Andrae DA. Effects of treatment with eluxadoline on abdominal pain in patients with IBS-D: Additional post hoc analyses of Phase 3 trials. Neurogastroenterol Motil 2020;32:e13774. [PMID: 31984655 DOI: 10.1111/nmo.13774] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
